Keyphrases
Hepatocellular Carcinoma
100%
Human Cancer
41%
MicroRNA
38%
Tumor
37%
Liver Cancer
32%
CpG Island Methylation
32%
In Cancer
25%
Epigenetics
24%
Cancer Cells
19%
Prostate Cancer
19%
Catenin
19%
Cellular Senescence
17%
Hepatocytes
16%
Senescence
16%
Non-cell Autonomous
13%
Advanced Hepatocellular Carcinoma
13%
Therapeutic Implications
13%
Mouse Model
13%
Immune Checkpoint Inhibitors
12%
Immune Evasion
12%
Tumor Suppressor miRNA
12%
Liver
12%
Non-coding RNA (ncRNA)
12%
CD8+ T Cells
11%
Histone Modification
11%
BRAF Inhibitor (BRAFi)
11%
Genetic Modification
11%
Tumor Growth
10%
Epigenetic Mechanisms
10%
Cancer Metastasis
10%
Programmed Death-ligand 1 (PD-L1)
10%
Tumor Cells
10%
Immune Response
9%
CTNNB1
9%
Tumor Suppressor Gene
9%
Oncogene
9%
Senescence-associated Secretory Phenotype
9%
Liver Regeneration
9%
Ultraconserved Region
9%
Inhibitor Activity
9%
Insulin-like Growth Factor 2 (IGF2)
9%
Transforming Growth Factor-β
9%
Hepatocellular Cancer
9%
Tumor Suppressor
8%
Tumor Heterogeneity
8%
Tumor Microenvironment
8%
Metastasis
8%
Senescent Cells
8%
Erlotinib
7%
Multikinase Inhibitor
7%
Biochemistry, Genetics and Molecular Biology
MicroRNA
34%
Cancer Cell
33%
Carcinogenesis
31%
Epigenetics
27%
CpG Island
27%
Tumor Suppressor Protein
23%
Mouse Model
22%
T Cell
21%
Catenin
21%
Tumor Progression
16%
DNA Methylation
15%
Genetics
14%
Hepatocyte
14%
Oncogene
13%
Kinase
13%
Phosphotransferase
13%
CD8
12%
Gene Mutation
12%
Transcriptomics
11%
Myeloid
10%
Immune Checkpoint Inhibitor
9%
Immune Evasion
9%
Liver Regeneration
9%
Epidermal Growth Factor Receptor
9%
KRAS
9%
Ontogeny
9%
Cancer Growth Factor
9%
Microbiome
9%
Programmed Cell Death 1
9%
Reprogramming
9%
Transcription Factors
8%
Genomics
8%
Germ Cell
7%
Epigenomics
7%
Epigenetics
7%
Cell Cycle Arrest
7%
Cell Cycle Checkpoint
7%
Tumor Suppressor Gene
7%
Cell Proliferation
6%
RNA-binding Protein
6%
Transmembrane Protein
6%
Immunocompetent Cell
6%
Gene Expression
6%
Promoter Region
6%
Small Hairpin RNA
6%
Small Interfering RNA
6%
Histone Modification
6%
Cell Death
6%
Non-Coding RNA
6%
Targeted Therapy
6%
Medicine and Dentistry
Hepatocellular Carcinoma
56%
Malignant Neoplasm
33%
Neoplasm
22%
Liver Cancer
18%
Carcinogenesis
17%
Tumor
17%
Immunotherapy
17%
Diseases
14%
Cellular Senescence
10%
Cancer
9%
Cancer Cell
9%
Liver Disease
9%
Ontogeny
9%
Metastatic Carcinoma
9%
Erlotinib
9%
Tumor Progression
8%
microRNA
8%
Prostate Cancer
7%
Tumor Suppressor Protein
7%
Hepatocyte
7%
Personalized Medicine
6%
Cholangiocarcinoma
6%
T Cell
6%
Fibrosis
6%
Phosphotransferase
5%
DNA Methylation
5%
Phosphotransferase Inhibitor
5%
Lung Tumor
5%
Epigenetic Mechanism
5%
Primary Tumor
5%
Oncogene
5%
Cancer Inhibition
5%
Leukemia
5%
Targeted Therapy
5%
Hepatic Stellate Cell
5%
Cadherin
5%
Oncogenic activity
5%
